Literature DB >> 6085428

Differentiation of normal and malignant human squamous epithelium in vivo and in vitro: a morphologic study.

J Knight, B A Gusterson, G Cowley, P Monaghan.   

Abstract

We report a light microscopic and ultrastructural analysis of the comparative degrees of differentiation seen in keratinocytes derived from the tongue and epidermis with those of a well-differentiated human squamous carcinoma cell line (LICR-LON-HN5). When growing on plastic substrates, all cultures had a similar morphology, with multilayering and the production of cornified envelopes. When cultured on collagen gels the structure was more organized, with keratohyalin granules and keratin whorl formation in both the normal and the malignant cultures. Normal keratinocytes injected into athymic mice produced epidermal cysts, while cells from the cell line produced well-differentiated squamous cell carcinomas, which were partially solid and partially cystic. the tumor was well organized, with identifiable basal cells, spinous cells, keratohyalin granules, and a prominent basal lamina at the stromal/epithelial interface. This model is to be developed for comparative studies between normal and malignant cells, with particular reference to basement membrane production and to investigations of the relative importance of extrinsic and intrinsic factors in the control of squamous differentiation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085428     DOI: 10.3109/01913128409141470

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  2 in total

1.  Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes.

Authors:  Surabhi Dangi-Garimella; Amanda J Redig; Mario A Shields; Mohammed A Siddiqui; Hidayatullah G Munshi
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

2.  Increased EGF receptors on human squamous carcinoma cell lines.

Authors:  G P Cowley; J A Smith; B A Gusterson
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.